Use of tivozanib to treat subjects with refractory cancer | Patent Publication Number 20220233516

US 20220233516 A1

Patent NumberUS 11504365 B2

Application Number17720619

Filled DateApr 14, 2022

Priority DateNov 5, 2018

Publication DateJul 28, 2022

Original AssigneeAveo Pharmaceutical

Current AssigneeAveo Pharmaceutical

Inventor/ApplicantsMichael N. Needle
Michael P. Bailey

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.